Literature DB >> 27238053

FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease.

Preethi Pirlamarla1, Rachel M Bond2.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been extensively used worldwide for both chronic and acute musculoskeletal and inflammatory conditions. Extensive evidence has linked NSAID use with adverse cardiovascular events. This review article aims to review the existing evidence on the risk of cardiovascular and coronary events in both selective and nonselective NSAIDs, the time course of NSAIDs associated with cardiovascular risk, and specific populations that may be at increased risk.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COX-2 inhibitors; Cardiovascular disease; Cardiovascular risk; Coronary artery disease; Nonselective NSAIDs; Nonsteroidal anti-inflammatory drugs; Rheumatologic disease

Mesh：

Substances：

Year:  2016        PMID： 27238053     DOI： 10.1016/j.tcm.2016.04.011

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


  11 in total

1.  Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.

Authors:  Gregory Castelli; Ashley Petrone; Jun Xiang; Carl Shrader; Dana King
Journal:  Am J Cardiovasc Drugs       Date:  2017-06       Impact factor: 3.571

2.  Effects of dissolved organic matter, feeding, and water flow on the bioconcentration of diclofenac in crucian carp (Carassius auratus).

Authors:  Guanghua Lu; Zhengxin Xie; Zhenghua Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-30       Impact factor: 4.223

3.  Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis.

Authors:  Ramanpreet Kaur; Dhimant Desai; Shantu Amin; Kaisar Raza; Aman Bhalla; Pooja Yadav; Naveen Kaushal
Journal:  Mol Cell Biochem       Date:  2022-08-24       Impact factor: 3.842

4.  Interaction between COX-2 and ER stress is involved in the apoptosis-induced myocardial ischemia/reperfusion injury.

Authors:  Wenhui Tao; Lingui Li; Junkai Hu; Shangxian Xu; Biying Wang; Jun Ding; Mian Zhang; Xiaowen Meng; Xiang Wei; Xisheng Shan; Ke Peng; Huayue Liu; Fuhai Ji
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 5.  The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.

Authors:  Carlota Recio; Francesco Maione; Asif J Iqbal; Nicola Mascolo; Vincenzo De Feo
Journal:  Front Pharmacol       Date:  2017-01-06       Impact factor: 5.810

Review 6.  Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke.

Authors:  Anna Kloska; Marcelina Malinowska; Magdalena Gabig-Cimińska; Joanna Jakóbkiewicz-Banecka
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

7.  Direct in situ labeling of target drugs with a fluorophore probe to improve MALDI-MS detection sensitivity in micro-liter plasma.

Authors:  Yi-Shan Li; Chi-Yu Lu
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

8.  Gene expression profiling of brain endothelial cells after experimental subarachnoid haemorrhage.

Authors:  Michael K Tso; Paul Turgeon; Bert Bosche; Charles K Lee; Tian Nie; Josephine D'Abbondanza; Jinglu Ai; Philip A Marsden; R Loch Macdonald
Journal:  Sci Rep       Date:  2021-04-09       Impact factor: 4.379

9.  Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain.

Authors:  Shailina Keshwani; Ivanna Grande; Michael Maguire; Amie Goodin; Scott M Vouri; Juan M Hincapie-Castillo
Journal:  JAMA Netw Open       Date:  2021-06-01

10.  Creating a mouse model resistant to induced ischemic stroke and cardiovascular damage.

Authors:  Qing-Lan Ling; Anita J Mohite; Emma Murdoch; Hironari Akasaka; Qun-Ying Li; Shui-Ping So; Ke-He Ruan
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.